Fundraising FoxBoulder Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Ambrosiabiosciencesambrosiabiosciences.cominAug 2024
Ambrosia Biosciences is a drug discovery company developing orally delivered, small molecule therapies for obesity and other metabolic disorders.
BiotechHealthtechLongevityBoulder, US
Nicholas Traggis(Executive Officer, Director)
BoardDavid Snitman(Director)William S. Marshall(Director)John Orwin(Director)
Board seatKyle Lefkoff· per SEC Form D
Co-investorsColorado BioScience AssociationBiotechnology Value Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.